Signal Transduction by PI3K/mTOR
PI3K/mTOR 的信号转导
基本信息
- 批准号:10578841
- 负责人:
- 金额:$ 48.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AgingAutomobile DrivingBiological AssayBiologyBiosensorCell NucleusCell physiologyCellsCellular AssayCessation of lifeCetuximabChemicalsClinicalColorCombined Modality TherapyComplexDNA Polymerase IIDNA Polymerase IIIDetectionDiabetes MellitusDiseaseDrug resistanceEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEventFDA approvedFRAP1 geneGenetic TranscriptionGoalsLocationMalignant NeoplasmsMediatingModelingMolecularNuclearNuclear TranslocationOncogenicPIK3CG genePathway interactionsPhase II Clinical TrialsPhosphotransferasesProcessRegulationReporterResearchResistanceReverse Transcriptase Polymerase Chain ReactionRoleSeriesSignal PathwaySignal TransductionSignaling MoleculeSpecificityTechnologyTestingToxic effectVariantXenograft Modelcancer therapycell growthmolecular actuatormouth squamous cell carcinomamultiplexed imagingnervous system disordernovelphosphoproteomicsrecruitresponsespatiotemporaltargeted cancer therapytooltranscriptome sequencingtumortumorigenesis
项目摘要
Project summary:
The overall goal of our research is to uncover the molecular and cellular mechanisms by which mTOR
signaling is spatially regulated and to elucidate the contribution of subcellular mTORC1 signaling to
tumorigenesis and cancer therapy resistance. The signaling pathway regulated by phosphatidylinositol 3-
kinase (PI3K) and mechanistic target of rapamycin (mTOR) regulates a number of processes that are critical
to cell physiology, and therefore is often dysregulated in diseases, including cancer. In particular, persistent
activation of the PI3K/mTOR signaling circuitry is the most frequent dysregulated signaling mechanism in oral
squamous cell carcinoma (OSCC), a disease that results in ~300,000 deaths each year worldwide, with 5-year
survival estimates of approximately 60%, despite aggressive multimodality therapies. Spatial
compartmentalization of PI3K/mTOR is not only critical for enhancing the signaling specificity, but also
required for proper functioning of the pathway. However, the mechanisms underlying spatial regulation of
PI3K/mTOR signaling remain poorly understood and it is not clear which subcellular pools of the signaling
molecules contribute to tumorigenesis and therapy resistance. We have assembled a strong interdisciplinary
team with complementary expertise, including Dr. Jin Zhang, an expert in chemical biology and kinase
signaling, Dr. J. Silvio Gutkind, a renowned cancer biologist whose lab has focused on the study of oncogenic
signaling pathways driving OSCC initiation and progression. In our previous studies, we have created novel
tools for studying the spatial regulation of mTOR signaling, including a fluorescent biosensor for tracking
mTOR Complex 1 (mTORC1) activity in living cells and an approach for achieving subcellular inhibition of
kinase signaling. Using these tools, we discovered novel mechanisms underlying regulation of nuclear
mTORC1. In the context of OSCC, we have shown that mTOR inhibition exerts potent antitumor activity in a
large series of genetically-defined and chemically-induced OSCC models and favorable clinical responses in a
recently completed clinical phase II trial (NCT01195922). The current proposal will develop new molecular
tools to interrogate the spatiotemporal regulation of mTORC1 signaling in living cells, elucidate the regulatory
mechanisms of nuclear mTORC1 signaling, and determine the functional roles of subcellular mTORC1
signaling in tumorigenesis and Cetuximab resistance in OSCC. Unravelling the function and regulation of
subcellular mTORC1 signaling should offer a path toward selective targeting of pathway components and yield
therapies with reduced toxicity and resistance.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jorge Silvio Gutkind其他文献
Jorge Silvio Gutkind的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jorge Silvio Gutkind', 18)}}的其他基金
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
联合靶向 HER3 致癌信号通路和 PD-1 作为 HNSCC 的新型多模式精准免疫疗法
- 批准号:
10536607 - 财政年份:2019
- 资助金额:
$ 48.35万 - 项目类别:
Multidisciplinary Educational Approach to Reducing Cancer Disparities
减少癌症差异的多学科教育方法
- 批准号:
10683194 - 财政年份:2019
- 资助金额:
$ 48.35万 - 项目类别:
Multidisciplinary Educational Approach to Reducing Cancer Disparities
减少癌症差异的多学科教育方法
- 批准号:
10246272 - 财政年份:2019
- 资助金额:
$ 48.35万 - 项目类别:
Multidisciplinary Educational Approach to Reducing Cancer Disparities
减少癌症差异的多学科教育方法
- 批准号:
10002204 - 财政年份:2019
- 资助金额:
$ 48.35万 - 项目类别:
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
靶向 EGFR-PI3K/mTOR 信号通路:基于网络的口腔癌精准治疗方法
- 批准号:
10439800 - 财政年份:2018
- 资助金额:
$ 48.35万 - 项目类别:
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
靶向 EGFR-PI3K/mTOR 信号通路:基于网络的口腔癌精准治疗方法
- 批准号:
10214590 - 财政年份:2018
- 资助金额:
$ 48.35万 - 项目类别:
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
刺激头颈癌中新抗原特异性 T 细胞反应
- 批准号:
10115173 - 财政年份:2018
- 资助金额:
$ 48.35万 - 项目类别:
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
刺激头颈癌中新抗原特异性 T 细胞反应
- 批准号:
10461025 - 财政年份:2018
- 资助金额:
$ 48.35万 - 项目类别:
相似海外基金
Establishment of a method for evaluating automobile driving ability focusing on frontal lobe functions and its application to accident prediction
以额叶功能为中心的汽车驾驶能力评价方法的建立及其在事故预测中的应用
- 批准号:
20K07947 - 财政年份:2020
- 资助金额:
$ 48.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the Effectiveness of Multi-Professional Collaborative Assessment of Cognitive Function and Automobile Driving Skills and Comprehensive Support
认知功能与汽车驾驶技能多专业协同评估效果评价及综合支持
- 批准号:
17K19824 - 财政年份:2017
- 资助金额:
$ 48.35万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of Flexible Automobile Driving Interface for Disabled People
残疾人灵活汽车驾驶界面开发
- 批准号:
25330237 - 财政年份:2013
- 资助金额:
$ 48.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Automobile driving among older people with dementia: the effect of an intervention using a support manual for family caregivers
患有痴呆症的老年人的汽车驾驶:使用家庭护理人员支持手册进行干预的效果
- 批准号:
23591741 - 财政年份:2011
- 资助金额:
$ 48.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)